Literature DB >> 10685132

C-reactive protein, inflammation, and coronary risk.

D A Morrow1, P M Ridker.   

Abstract

Data have revealed interactions between baseline concentration of hs-CRP and the efficacy of common pharmacologic therapies in primary and secondary prevention, suggesting not only that it may be possible to modify the increased risk associated with elevated hs-CRP, but also that inflammatory markers may be useful in targeting preventive therapies. Inflammatory markers may become a valuable component of routine cardiovascular risk assessment.

Entities:  

Mesh：

Substances：

Year:  2000        PMID： 10685132     DOI： 10.1016/s0025-7125(05)70211-x

Source DB:  PubMed          Journal:  Med Clin North Am        ISSN： 0025-7125            Impact factor:   5.456


  30 in total

1.  Improvement of atherosclerotic markers in non-diabetic patients after bariatric surgery.

Authors:  Mohamed Hassan Saleh; Marcelo Chiara Bertolami; Jorge Eduardo Assef; Mohamed Ibrahim Taha; Wilson de Freitas; Ana Claudia Gomes Petisco; Rodrigo Bellio Mattos Barretto; David Costa Le Bihan; Jose Eduardo Martins Barbosa; Carlos Alberto de Jesus; Amanda Guerra Moraes Rego Sousa
Journal:  Obes Surg       Date:  2012-11       Impact factor: 4.129

Review 2.  Stress and health: psychological, behavioral, and biological determinants.

Authors:  Neil Schneiderman; Gail Ironson; Scott D Siegel
Journal:  Annu Rev Clin Psychol       Date:  2005       Impact factor: 18.561

3.  The relationship between religious service attendance and coronary heart disease and related risk factors in Saskatchewan, Canada.

Authors:  Ananya Tina Banerjee; Michael H Boyle; Sonia S Anand; Patricia H Strachan; Mark Oremus
Journal:  J Relig Health       Date:  2014-02

4.  Sustained low-grade pro-inflammatory state in unmedicated, remitted women with major depressive disorder as evidenced by elevated serum levels of the acute phase proteins C-reactive protein and serum amyloid A.

Authors:  Mitchel A Kling; Salvatore Alesci; Gyorgy Csako; Rene Costello; David A Luckenbaugh; Omer Bonne; Roman Duncko; Wayne C Drevets; Husseini K Manji; Dennis S Charney; Philip W Gold; Alexander Neumeister
Journal:  Biol Psychiatry       Date:  2006-12-18       Impact factor: 13.382

5.  Dietary patterns are linked to cardiovascular risk factors but not to inflammatory markers in Alaska Eskimos.

Authors:  Sigal Eilat-Adar; Mihriye Mete; Elizabeth D Nobmann; Jiaqiong Xu; Richard R Fabsitz; Sven O E Ebbesson; Barbara V Howard
Journal:  J Nutr       Date:  2009-10-14       Impact factor: 4.798

Review 6.  Inflammatory pathways in children with insufficient or disordered sleep.

Authors:  Jinkwan Kim; Fahed Hakim; Leila Kheirandish-Gozal; David Gozal
Journal:  Respir Physiol Neurobiol       Date:  2011-05-05       Impact factor: 1.931

7.  Bromelain and cardiovascular risk factors in diabetes: An exploratory randomized, placebo controlled, double blind clinical trial.

Authors:  Chit Moy Ley; Qing Ni; Xing Liao; Huai-Lin Gao; Nicola Robinson
Journal:  Chin J Integr Med       Date:  2016-07-13       Impact factor: 1.978

8.  A two-step genetic study on quantitative precursors of coronary artery disease in a homogeneous Indian population: case-control association discovery and validation by transmission-disequilibrium test.

Authors:  Sanjukta Mallik; Partha P Majumder
Journal:  J Biosci       Date:  2011-12       Impact factor: 1.826

Review 9.  Myocardial infarction, stroke, and sudden cardiac death may be prevented by influenza vaccination.

Authors:  David G Meyers
Journal:  Curr Atheroscler Rep       Date:  2003-03       Impact factor: 5.113

10.  Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood.

Authors:  Najib Aziz; John L Fahey; Roger Detels; Anthony W Butch
Journal:  Clin Diagn Lab Immunol       Date:  2003-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.